Navigate Your Biggest Life Science Commercial Crossroads with Intelligence & Experience.

Go beyond the data. Our premium GTM Crossroads service delivers a deep-dive strategic report powered by our Life Science Intelligence Engine and includes a direct consultation with a former healthcare CEO who has faced your challenges.

When you’re facing a complex, multi-faceted challenge that will define your commercial future, you need more than a report—you need wisdom. The GTM Crossroads service combines the raw power of our Life Science Intelligence Engine with the invaluable, practical insights of a former healthcare CEO.

For a starting investment of $2,497, you receive a masterful 8-15 page strategic report in 3-5 days, followed by a 15-minute strategy session to pressure-test the findings and translate them into actionable reality.

Why Crossroads is the Ultimate Strategic Advantage

Deep-Dive Analysis

We tackle complex problems requiring integrated analysis across regulatory, reimbursement, clinical, and commercial domains.

The Engine's Power

Our life science trained AI performs the heavy lifting of data synthesis and initial analysis at an unprecedented speed and depth.

The Human Edge

Your engagement includes a 15-minute post-engagement call with a former healthcare CEO who provides context, challenges assumptions, and helps you apply the strategy to the real world.

The Crossroads Deliverable: Your Comprehensive Strategy Package

  • An 8-15 Page Master Strategic Report with a detailed Go-Forward Strategy (GFS).
  • Integrated Analysis across all critical domains (e.g., market entry, reimbursement pathways, revenue architecture).
  • Data-Driven Models & Frameworks to support your planning.
  • Post-Report CEO Connection: A 15-minute direct consultation to discuss the findings and their practical application.

Components of the Life Science Logic Intelligence Engine…just a sampling

Life Sciences Domain Knowledge

  • Regulatory Pathways: FDA 510(k), PMA, De Novo, IVD regulations, EMA processes
  • Reimbursement: CPT codes, coverage pathways, health economics
  • Clinical Development: Trial design, endpoints, clinical adoption strategies
  • Market Segments:
    Biopharma (discovery, preclinical, clinical, commercial)
    Medical devices (Class I/II/III strategies)
    Diagnostics (LDT, IVD, companion diagnostics)
    Digital health (SaMD, remote monitoring)
  • Stakeholders: KOLs, payers, providers, patients, health systems

Ideal For Complex Challenges Like:

“What clinical evidence, real-world evidence, and health economic data do we need to generate to support optimal reimbursement and market access for our device? What’s the integrated evidence generation strategy?”

Client Profile

  • Medical device company, 6 months post-FDA approval
  • Minimal clinical data beyond pivotal trial
  • Payers requesting more outcomes data
  • Limited budget for evidence generation

Why Crossroads (Not Sprint)

  • Requires integration of clinical, RWE, HEOR, and market access strategies
  • Multiple evidence types with different timelines, costs, and stakeholders
  • Resource allocation across evidence portfolio
  • Evidence strategy must align to commercial and reimbursement milestones

Crossroads Deliverables

  • Combined portfolio positioning strategy
  • Sales force integration plan (territories, compensation, reporting)
  • Channel strategy rationalization (distributor consolidation, GPO contracts)
  • Unified brand architecture and positioning
  • Cross-selling and upselling opportunities
  • Customer transition and retention plan
  • Revenue synergy identification and capture plan
  • 18-month integration roadmap with milestones
  • Integration risk assessment and mitigation
  • Combined KPIs and success metrics

Answers When You Need Them

No calls, no delays. Just intelligence-driven results.

Complete Questionnaire Now
Contact Us for a Custom Quote